BlackRock Inc. boosted its position in shares of Innospec Inc. (NASDAQ:IOSP) by 8.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,460,770 shares of the specialty chemicals company’s stock after purchasing an additional 284,081 shares during the quarter. BlackRock Inc. owned approximately 0.14% of Innospec worth $244,330,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. First Trust Advisors LP lifted its position in shares of Innospec by 35.6% in the third quarter. First Trust Advisors LP now owns 32,447 shares of the specialty chemicals company’s stock valued at $2,000,000 after acquiring an additional 8,520 shares in the last quarter. Crossmark Global Holdings Inc. purchased a new stake in shares of Innospec in the third quarter valued at $302,000. Victory Capital Management Inc. lifted its position in shares of Innospec by 33.4% in the third quarter. Victory Capital Management Inc. now owns 3,629 shares of the specialty chemicals company’s stock valued at $224,000 after acquiring an additional 909 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Innospec by 24.4% in the third quarter. American Century Companies Inc. now owns 449,089 shares of the specialty chemicals company’s stock valued at $27,686,000 after acquiring an additional 88,053 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its position in shares of Innospec by 0.4% in the third quarter. Principal Financial Group Inc. now owns 426,095 shares of the specialty chemicals company’s stock valued at $26,269,000 after acquiring an additional 1,811 shares in the last quarter. Institutional investors own 92.37% of the company’s stock.
In related news, insider David Earl Williams sold 3,142 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $68.54, for a total transaction of $215,352.68. Following the transaction, the insider now directly owns 16,676 shares in the company, valued at $1,142,973.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Ian Cleminson sold 2,261 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $68.55, for a total value of $154,991.55. Following the transaction, the chief financial officer now owns 26,685 shares in the company, valued at $1,829,256.75. The disclosure for this sale can be found here. Insiders have sold 8,554 shares of company stock worth $584,767 over the last quarter. 2.02% of the stock is currently owned by company insiders.
Innospec Inc. (IOSP) opened at $70.45 on Wednesday. Innospec Inc. has a 12-month low of $54.10 and a 12-month high of $74.30. The firm has a market capitalization of $1,693.56, a PE ratio of 28.07 and a beta of 1.13. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.34 and a current ratio of 2.15.
Innospec (NASDAQ:IOSP) last released its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.47 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.34. Innospec had a return on equity of 15.57% and a net margin of 4.73%. The firm had revenue of $353.80 million for the quarter. analysts predict that Innospec Inc. will post 4.3 EPS for the current fiscal year.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.